Wednesday, 31 July 2019

Gilead results beat Street estimates as demand grows for HIV drug

Gilead Sciences beat Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by higher sales of HIV treatments.

from Earnings https://ift.tt/2MrXJxx
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)